Targeting the natriuretic peptide system represents a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with hypertension, diabetes, and heart or renal failure.
This review discusses the role of the natriuretic peptide system and neurohormonal factors in cardiorenal protection for patients with heart failure, renal failure, hypertension, and diabetes.
Significant progress has been made in the understanding of the neurohormonal factors that contribute to the progression of chronic renal and cardiac failure and the development of target-organ damage in patients with hypertension and diabetes. We herein review some of these advances, including a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with these disorders.
McFarlane et al. (Mon,) conducted a review in Chronic renal and cardiac failure, hypertension, and diabetes. Natriuretic peptide system targeted therapies was evaluated. Targeting the natriuretic peptide system represents a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with hypertension, diabetes, and heart or renal failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: